SCHEMBL75746

SCHEMBL75746

Oc1ccc(OC(F)(F)C(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
ESR1 P03372 4/20 0.44
ESR2 Q92731 4/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.42
CETP P11597 1/20 0.41
MAPT P10636 1/20 0.38
EPHX2 P34913 1/20 0.38
LTA4H P09960 2/20 0.38
NR1H2 P55055 1/20 0.38
BAX Q07812 1/20 0.38
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1907911 0.88 ALDH1A1 (0.48) ALDH1A1TSHRHSD17B10TRPV1KDM4E
SCHEMBL10932957 0.85 ALDH1A1 (0.42) ALDH1A1TSHRHSD17B10TRPV1ESR1
SCHEMBL10703814 0.82 ALDH1A1 (0.40) ALDH1A1TSHRHSD17B10TRPV1ESR1
SCHEMBL4456125 0.79 ALDH1A1 (0.43) ALDH1A1TSHRHSD17B10TRPV1CETP
SCHEMBL221511 0.78 MAPT (0.52) ALDH1A1TSHRHSD17B10ESR1ESR2
SCHEMBL16302584 0.77 ALDH1A1 (0.42) ALDH1A1TSHRHSD17B10TRPV1KDM4E
SCHEMBL3945050 0.77 TRPV1 (0.51) ALDH1A1TSHRHSD17B10TRPV1MEN1
SCHEMBL2029020 0.77 ALDH1A1 (0.44) ALDH1A1TSHRHSD17B10TRPV1MEN1
SCHEMBL2707618 0.77 TRPV1 (0.45) ALDH1A1TSHRHSD17B10TRPV1MEN1
SCHEMBL12403373 0.77 CA1 (0.50) ALDH1A1TSHRHSD17B10TRPV1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8129412-B2 Hydantoin derivatives useful as metalloproteinase inhibitors ASTRAZENECA AB (SE) 2012-03-06 US disclosed
EP-1828166-B1 HYDANTOIN DERIVATIVES USEFUL AS METALLOPROTEINASE INHIBITORS ASTRAZENECA AB (SE) 2009-07-22 EP disclosed
US-20080280950-A1 Hydantoin Derivatives Useful as Metalloproteinase Inhibitors ASTRAZENECA AB (SE) 2008-11-13 US disclosed
US-4551448-A INSECTICIDES, MITICIDES BASF AKTIENGESELLSCHAFT (DE) 1985-11-05 US disclosed
EP-0091598-B1 FLUORO-ETHOXYPHENYL-(DI)-THIOPHOSPHORIC-ACID ESTERS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES BASF Aktiengesellschaft (DE) 1985-08-07 EP disclosed
EP-0091598-A2 Fluoro-ethoxyphenyl-(di)-thiophosphoric-acid esters, process for their preparation and their use as pesticides BASF Aktiengesellschaft (DE) 1983-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280950-A1 Hydantoin Derivatives Useful as Metalloproteinase Inhibitors MMP3, MMP9, MMP2 ALDH1A1 528/4885TSHR 3130/4885HSD17B10 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.